Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry.
Ontology highlight
ABSTRACT: Furin is a human serine protease responsible for activating numerous physiologically relevant cell substrates and is also involved in the development of various pathological conditions, including inflammatory diseases, cancers, and viral and bacterial infections. Therefore, compounds with the ability to inhibit furin's proteolytic action are regarded as potential therapeutics. Here we took the combinatorial chemistry approach (library consisting of 2000 peptides) to obtain new, strong, and stable peptide furin inhibitors. The extensively studied trypsin inhibitor SFTI-1 was used as a leading structure. A selected monocylic inhibitor was further modified to finally yield five mono- or bicyclic furin inhibitors with values of K i in the subnanomolar range. Inhibitor 5
SUBMITTER: Gitlin-Domagalska A
PROVIDER: S-EPMC10107917 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA